LigaChem Biosciences

141080.KQ

79.01 USD

-2.71

-3.32%

Overview

Last close

79.01 usd

Market cap

2.87B usd

52 week high

99.94 usd

52 week low

35.31 usd

Target price

115.88 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

26.6135

Price/Book Value

6.6802

Enterprise Value

2.52B usd

EV/Revenue

23.4313

EV/EBITDA

109.4417

Key financials

Revenue TTM

107.73M usd

Gross Profit TTM

95.84M usd

EBITDA TTM

-5.36M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

502.02M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.